LeadArt Biotechnologies Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
60
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$6M
- Investors
-
2
LeadArt Biotechnologies General Information
Description
Provider of drug discovery services intended to generate numerous early drug discovery pipelines. The company's service focuses on novel drug target identification using chemoproteomics technologies, enabling clients in the pharmaceutical industry to get an assistance drug discovery process.
Contact Information
Website
www.leadartech.comCorporate Office
- Building C3, Qidi Science and Technology Park
- Zhongguan West Road, Zhuangshi Street, Zhenhai District
- Ningbo, Zhejiang 315201
- China
Corporate Office
- Building C3, Qidi Science and Technology Park
- Zhongguan West Road, Zhuangshi Street, Zhenhai District
- Ningbo, Zhejiang 315201
- China
LeadArt Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 19-Jul-2022 | $6M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 05-May-2018 | Completed | Generating Revenue |
LeadArt Biotechnologies Comparisons
Industry
Financing
Details
LeadArt Biotechnologies Competitors (26)
One of LeadArt Biotechnologies’s 26 competitors is Almac Group, a Venture Capital-Backed company based in Craigavon, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Almac Group | Venture Capital-Backed | Craigavon, United Kingdom | ||||
| Silence Therapeutics | Formerly VC-backed | London, United Kingdom | ||||
| GenScript | Formerly VC-backed | Nanjing, China | ||||
| Denovo Biopharma | Venture Capital-Backed | Hangzhou, China | ||||
| Roche | Corporation | Basel, Switzerland |
LeadArt Biotechnologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
LeadArt Biotechnologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
LeadArt Biotechnologies Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Yongchao Venture Capital | Venture Capital | Minority | ||
| Zfounder | Venture Capital | Minority |
LeadArt Biotechnologies FAQs
-
When was LeadArt Biotechnologies founded?
LeadArt Biotechnologies was founded in 2017.
-
Where is LeadArt Biotechnologies headquartered?
LeadArt Biotechnologies is headquartered in Ningbo, China.
-
What is the size of LeadArt Biotechnologies?
LeadArt Biotechnologies has 60 total employees.
-
What industry is LeadArt Biotechnologies in?
LeadArt Biotechnologies’s primary industry is Drug Discovery.
-
Is LeadArt Biotechnologies a private or public company?
LeadArt Biotechnologies is a Private company.
-
What is LeadArt Biotechnologies’s current revenue?
The current revenue for LeadArt Biotechnologies is .
-
How much funding has LeadArt Biotechnologies raised over time?
LeadArt Biotechnologies has raised $20M.
-
Who are LeadArt Biotechnologies’s investors?
Yongchao Venture Capital and Zfounder have invested in LeadArt Biotechnologies.
-
Who are LeadArt Biotechnologies’s competitors?
Almac Group, Silence Therapeutics, GenScript, Denovo Biopharma, and Roche are some of the 26 competitors of LeadArt Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
